Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 856 results for "glenmark"

Sell Glenmark Pharma Ltd with a target of Rs 721: Sandeep Wagle

In a chat with ET Now, Sandeep Wagle, Founder & CEO, Power My Wealth, shares his view on Glenmark Pharma Ltd. ET Now: What is your call on Glenmark Pharma Ltd? Sandeep Wagle: Glenmark Pharma Ltd is a 'SELL' call with a target of Rs 721 and a ... Economic Times, 3 days ago

23 images for glenmark

NDTV Profit, 3 days ago
Sify, 3 days ago
NDTV Profit, 3 days ago
Business Today India, 3 weeks ago
KXXV-TV, 1 week ago
Livemint.com, 3 weeks ago
Resource Investing News, 2 weeks ago
NDTV Profit, 1 month ago
NDTV Profit, 1 month ago
Livemint.com, 1 month ago

Glenmark, Aurobindo Pharma to get astro support: Gupta

According to Satish Gupta of astrostocktips, Strides Arcolab, Divis Labs, Wockhardt, Glenmark Pharma and Aurobindo Pharma will get astro support.
 Money Control1 week ago Divis Labs, Glenmark, Ranbaxy to get astro support: Gupta  Money Control1 week ago Strides Arcolab, Cipla to get astro support: Satish Gupta  Money Control2 weeks ago TCS, Wipro, Glenmark, Ranbaxy to get astro support: Gupta  Money Control2 weeks ago

Buy Glenmark Pharma; target of Rs 913: Firstcall

Brokerage house Firstcall Research is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target price of Rs 913 in its research report dated December 04, 2014.
 Money Control2 days ago Buy Glenmark Pharma; target of Rs 873: Motilal Oswal  Money Control3 weeks ago Buy Glenmark Pharma, says Rahul Mohindar  Money Control1 month ago Hold Glenmark Pharma; target of Rs 805: Sharekhan  Money Control1 month ago

Rouble fallout: Dr Reddy's, Ranbaxy's profit in trouble

Depreciation of the Russian currency poses a risk to the profitability of Indian pharma companies such as Dr Reddy's, Glenmark and Ranbaxy. Russia, a key market for these companies, contributes 5% of overall Indian pharma exports. RussiaCIS ...
 Economic Times2 days ago Rouble fallout: Indian pharma companies need a cure to beat emerging crisis  Times of India2 days ago Dr Reddy's slips 1.2% after Russian rouble crumbles  Moneycontrol.com2 weeks ago

Trading Strategies for Glenmark, Dr Reddys Lab, Sun Pharma, Lupin, Divis Lab

S&P CNX NIFTY CMP 8029.80 Near Term: Techncal bounce could be expected on charts whereas resistance on charts is expected around 8100.00 Best trading strategy for traders would be buy on dips. Related Stories No Related Stories Found ...
 Smart Investor2 days ago
Reuters

Pharma exporters slump; EM currency rout hurts

Reuters Market Eye - Pharmaceutical stocks slump - Glenmark Pharmaceutical (GLEN.NS) falls 6 pct, Aurobindo Pharma (ARBN.NS) slumps 6.8 pct, Lupin (LUPN.NS) loses 5.3 pct. Ranbaxy Laboratories (RANB.NS) down 4 pct, Cipla (CIPL.NS) loses 3.6 pct, Sun ...
 Yahoo! Finance3 days ago Lupin, Glenmark Pharma Slump; EM Currency Rout Hurts  NDTV Profit3 days ago
[x]  

Buy Glenmark Pharma: Sudarshan Sukhani

According to Sudarshan Sukhani of s2analytics.com, one can buy Glenmark Pharma on dips.
 Money Control2 weeks ago Buy Glenmark, HUL, Shriram Transport: Sudarshan Sukhani  Money Control1 month ago Buy Dr Reddys Lab, Glenmark Pharma: Sukhani  Money Control1 month ago Buy Glenmark Pharma, PNB, TCS: Sudarshan Sukhani  Money Control2 months ago

Glenmark Pharmaceuticals announces resignation of director

This page uses frames, but your browser doesn't
 Capital Market3 weeks ago Glenmark Pharmaceuticals begins Phase II clinical trail  Capital Market1 month ago Glenmark Pharmaceuticals to hold EGM  Capital Market1 month ago Glenmark Pharmaceuticals to hold board meeting  Business Standard2 months ago
[x]  
Money Control

Glenmark Pharmaceuticals : SEPTEMBER PROFIT GROWS BY 7 PERCENT

Glenmark Pharmaceuticals Ltd has reported a net profit of Rs165.07 crore for Jul- Sep 2014 , up seven percent year-on- year. It had recorded a net profit of Rs154.29 crore in Jul- Sep 2013 . Its revenues were at Rs1,680.7 crore ( Rs1,463.38 ...
 4 Traders1 month ago Glenmark consolidated net profit up by 7% in Q2  PharmaBiz1 month ago Glenmark Pharma gains on reporting 7% rise in Q2 consolidated net profit  Indian-Commodity1 month ago Pharmaceuticals Newsletter - October 27 to 31, 2014  India Infoline1 month ago
[x]  

Buy Hexaware Technologies, says Manoj Murlidharan

M He further added, Glenmark Pharma in last precisely around 18-19 odd session we have seen a good VWAP based buying because the monthly weighted average price is where we have seen this cash based delivery accumulate. So, that is a good trend so ...
 Moneycontrol.com2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less